ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

AGLE Aeglea BioTherapeutics Inc

12.01
0.00 (0.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 3.64M1.36M625k174k168k198k688k0
Operating Income -20.44M-24.44M-22.42M-18.76M-19.16M-18.81M-159.25M-32.95M
Pre Tax Income -20.42M-24.44M-22.29M-18.44M-18.78M-18.46M-217.07M-40.1M
Net Income -20.45M-24.44M-22.32M-18.23M-18.82M-18.42M-217.08M-40.16M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -20.46M-24.47M-22.42M-18.73M-19.17M-18.88M-159.25M-16.08M
EBITDA -20.03M-24.04M-22.05M-18.35M-18.94M-18.42M-158.89M-32.95M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 4.63M5.21M3.89M0018.74M2.33M886k
Operating Income -21.91M-27.68M-45.46M-80.33M-81.48M-65.65M-84.78M-258.75M
Pre Tax Income -21.7M-27.24M-44.35M-78.25M-80.89M-65.66M-83.95M-338.82M
Net Income -21.7M-27.24M-44.35M-78.25M-80.89M-65.8M-83.82M-338.79M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.734-0.83-1.101-1.73-1.262-1.005-1.079-16.776
EBIT -21.94M-27.72M-45.52M-80.4M-81.49M-65.77M-84.79M-261.43M
EBITDA -21.77M-27.43M-45.17M-79.92M-80.49M-64.07M-83.38M-258.01M

Your Recent History

Delayed Upgrade Clock